RankingsPricing
  1. US-listed companies
  2. ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC.ADMA

Market cap
$4.4B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Product Revenue---------81154-
License Revenue---------142,834142,834-
REVENUES1367112317294281154258
Cost of product revenue669,05624462942406180119169
Gross profit449,0621234-6,403,761-25,209,345-10,155,155-19,071,64313589
Research and development3910786426443
Plasma center operating expenses22455782412184
Amortization of intangible assets-----1844,938844,938715,353111
Selling, general and administrative---------435259
Total operating expenses818222328627771107607567
INCOME (LOSS) FROM OPERATIONS-7,909,169-15,042,431-16,018,533-15,513,807-17,330,395-39,309,996-60,288,944-41,424,327-64,914,877-58,373,741-39,365,08022
Interest income--------288,12634,53244,8332
Interest expense30,683618,22512236912131925
Loss on extinguishment of debt----719,097--1,210,216--9,962,495991,797--6,669,941-26
Other expense------10,144-127,121-227,322-128,528-251,575-634,389-0
Other expense, net--484,815-1,346,354-2,456,123-2,184,756-4,448,979-5,454,501-6,854,990-10,833,671-13,273,877-26,538,870-50
NET LOSS-7,301,313-15,527,246-16,813,163-17,969,930-19,515,151-43,758,975-65,743,445-48,279,317-75,748,548-71,647,618-65,903,950-28
BASIC LOSS PER COMMON SHARE (in dollars per share)----------0.51-0.33-0.13
DILUTED LOSS PER COMMON SHARE (in dollars per share)----------0.51-0.33-0.13
Product Revenue---------81154-
License Revenue---------142,834142,834-
REVENUES1367112317294281154258
Cost of product revenue669,05624462942406180119169
Gross profit449,0621234-6,403,761-25,209,345-10,155,155-19,071,64313589
Research and development3910786426443
Plasma center operating expenses22455782412184
Amortization of intangible assets-----1844,938844,938715,353111
Selling, general and administrative---------435259
Total operating expenses818222328627771107607567
INCOME (LOSS) FROM OPERATIONS-7,909,169-15,042,431-16,018,533-15,513,807-17,330,395-39,309,996-60,288,944-41,424,327-64,914,877-58,373,741-39,365,08022
Interest income--------288,12634,53244,8332
Interest expense30,683618,22512236912131925
Loss on extinguishment of debt----719,097--1,210,216--9,962,495991,797--6,669,941-26
Other expense------10,144-127,121-227,322-128,528-251,575-634,389-0
Other expense, net--484,815-1,346,354-2,456,123-2,184,756-4,448,979-5,454,501-6,854,990-10,833,671-13,273,877-26,538,870-50
NET LOSS-7,301,313-15,527,246-16,813,163-17,969,930-19,515,151-43,758,975-65,743,445-48,279,317-75,748,548-71,647,618-65,903,950-28
BASIC LOSS PER COMMON SHARE (in dollars per share)----------0.51-0.33-0.13
DILUTED LOSS PER COMMON SHARE (in dollars per share)----------0.51-0.33-0.13